2D miR_HR1_12
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nfatc2
|
ENSMUSG00000027544.10 | nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Nfatc2 | mm10_v2_chr2_-_168590315_168590372 | 0.20 | 5.4e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr8_-_38661508 | 2.73 |
ENSMUST00000118896.1
|
Sgcz
|
sarcoglycan zeta |
chrX_-_61185558 | 2.61 |
ENSMUST00000166381.1
|
Cdr1
|
cerebellar degeneration related antigen 1 |
chr8_+_105427634 | 1.54 |
ENSMUST00000067305.6
|
Lrrc36
|
leucine rich repeat containing 36 |
chr5_-_123141067 | 1.30 |
ENSMUST00000162697.1
ENSMUST00000160321.1 ENSMUST00000159637.1 |
AI480526
|
expressed sequence AI480526 |
chr17_-_91088726 | 1.30 |
ENSMUST00000072671.7
ENSMUST00000174331.1 ENSMUST00000161402.3 ENSMUST00000054059.8 |
Nrxn1
|
neurexin I |
chr5_-_123140135 | 1.30 |
ENSMUST00000160099.1
|
AI480526
|
expressed sequence AI480526 |
chr18_+_36939178 | 1.24 |
ENSMUST00000115662.2
|
Pcdha2
|
protocadherin alpha 2 |
chr1_-_9962809 | 1.22 |
ENSMUST00000097824.2
|
Gm10567
|
predicted gene 10567 |
chr18_+_37484955 | 1.20 |
ENSMUST00000053856.4
|
Pcdhb17
|
protocadherin beta 17 |
chr11_+_61065798 | 1.14 |
ENSMUST00000041944.2
ENSMUST00000108717.2 |
Kcnj12
|
potassium inwardly-rectifying channel, subfamily J, member 12 |
chr2_-_94264713 | 0.98 |
ENSMUST00000129661.1
|
E530001K10Rik
|
RIKEN cDNA E530001K10 gene |
chr12_-_44210061 | 0.95 |
ENSMUST00000015049.3
|
Dnajb9
|
DnaJ (Hsp40) homolog, subfamily B, member 9 |
chr11_-_31824463 | 0.93 |
ENSMUST00000129425.1
ENSMUST00000126265.1 |
D630024D03Rik
|
RIKEN cDNA D630024D03 gene |
chr1_+_195017399 | 0.92 |
ENSMUST00000181273.1
|
A330023F24Rik
|
RIKEN cDNA A330023F24 gene |
chr11_-_31824518 | 0.90 |
ENSMUST00000134944.1
|
D630024D03Rik
|
RIKEN cDNA D630024D03 gene |
chr15_+_10249560 | 0.90 |
ENSMUST00000134410.1
|
Prlr
|
prolactin receptor |
chrX_+_164438039 | 0.87 |
ENSMUST00000033755.5
|
Asb11
|
ankyrin repeat and SOCS box-containing 11 |
chr8_+_62951195 | 0.87 |
ENSMUST00000118003.1
|
Spock3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 3 |
chr3_-_90465858 | 0.86 |
ENSMUST00000029540.6
|
Npr1
|
natriuretic peptide receptor 1 |
chr10_+_115817247 | 0.84 |
ENSMUST00000035563.7
ENSMUST00000080630.3 ENSMUST00000179196.1 |
Tspan8
|
tetraspanin 8 |
chr19_-_5845471 | 0.83 |
ENSMUST00000174287.1
ENSMUST00000173672.1 |
Neat1
|
nuclear paraspeckle assembly transcript 1 (non-protein coding) |
chr1_+_60181495 | 0.80 |
ENSMUST00000160834.1
|
Nbeal1
|
neurobeachin like 1 |
chr7_-_4546567 | 0.80 |
ENSMUST00000065957.5
|
Syt5
|
synaptotagmin V |
chr12_-_101819048 | 0.80 |
ENSMUST00000021603.8
|
Fbln5
|
fibulin 5 |
chr6_-_124769548 | 0.79 |
ENSMUST00000149652.1
ENSMUST00000112476.1 ENSMUST00000004378.8 |
Eno2
|
enolase 2, gamma neuronal |
chr4_+_115088708 | 0.78 |
ENSMUST00000171877.1
ENSMUST00000177647.1 ENSMUST00000106548.2 ENSMUST00000030488.2 |
Pdzk1ip1
|
PDZK1 interacting protein 1 |
chr18_+_37742088 | 0.75 |
ENSMUST00000003599.6
|
Pcdhga9
|
protocadherin gamma subfamily A, 9 |
chr5_+_66968961 | 0.73 |
ENSMUST00000132991.1
|
Limch1
|
LIM and calponin homology domains 1 |
chr6_-_5256226 | 0.72 |
ENSMUST00000125686.1
ENSMUST00000031773.2 |
Pon3
|
paraoxonase 3 |
chr18_+_36952621 | 0.70 |
ENSMUST00000115661.2
|
Pcdha2
|
protocadherin alpha 2 |
chr3_+_122729158 | 0.70 |
ENSMUST00000066728.5
|
Pde5a
|
phosphodiesterase 5A, cGMP-specific |
chr3_-_75451818 | 0.70 |
ENSMUST00000178270.1
|
Wdr49
|
WD repeat domain 49 |
chr19_-_5796924 | 0.70 |
ENSMUST00000174808.1
|
Malat1
|
metastasis associated lung adenocarcinoma transcript 1 (non-coding RNA) |
chr15_+_10223974 | 0.69 |
ENSMUST00000128450.1
ENSMUST00000148257.1 ENSMUST00000128921.1 |
Prlr
|
prolactin receptor |
chr11_-_70656467 | 0.69 |
ENSMUST00000131642.1
|
Gm12319
|
predicted gene 12319 |
chr7_-_110862944 | 0.68 |
ENSMUST00000033050.3
|
Lyve1
|
lymphatic vessel endothelial hyaluronan receptor 1 |
chr1_-_91459254 | 0.67 |
ENSMUST00000069620.8
|
Per2
|
period circadian clock 2 |
chr2_-_103283760 | 0.67 |
ENSMUST00000111174.1
|
Ehf
|
ets homologous factor |
chr5_+_66968559 | 0.66 |
ENSMUST00000127184.1
|
Limch1
|
LIM and calponin homology domains 1 |
chr6_+_96113146 | 0.66 |
ENSMUST00000122120.1
|
Fam19a1
|
family with sequence similarity 19, member A1 |
chr13_-_23622502 | 0.66 |
ENSMUST00000062045.2
|
Hist1h1e
|
histone cluster 1, H1e |
chr1_+_87264345 | 0.65 |
ENSMUST00000118687.1
ENSMUST00000027472.6 |
Efhd1
|
EF hand domain containing 1 |
chr6_+_29853746 | 0.65 |
ENSMUST00000064872.6
ENSMUST00000152581.1 ENSMUST00000176265.1 ENSMUST00000154079.1 |
Ahcyl2
|
S-adenosylhomocysteine hydrolase-like 2 |
chr4_-_42168603 | 0.64 |
ENSMUST00000098121.3
|
Gm13305
|
predicted gene 13305 |
chr9_-_53706211 | 0.63 |
ENSMUST00000068449.3
|
Rab39
|
RAB39, member RAS oncogene family |
chr11_+_75468040 | 0.63 |
ENSMUST00000043598.7
ENSMUST00000108435.1 |
Tlcd2
|
TLC domain containing 2 |
chr11_+_9048575 | 0.63 |
ENSMUST00000043285.4
|
Gm11992
|
predicted gene 11992 |
chr5_+_30853796 | 0.62 |
ENSMUST00000126284.1
|
Mapre3
|
microtubule-associated protein, RP/EB family, member 3 |
chr10_+_69213084 | 0.62 |
ENSMUST00000163497.1
ENSMUST00000164212.1 ENSMUST00000067908.7 |
Rhobtb1
|
Rho-related BTB domain containing 1 |
chr11_+_70647258 | 0.61 |
ENSMUST00000037534.7
|
Rnf167
|
ring finger protein 167 |
chr8_+_76902277 | 0.61 |
ENSMUST00000109912.1
ENSMUST00000128862.1 ENSMUST00000109911.1 |
Nr3c2
|
nuclear receptor subfamily 3, group C, member 2 |
chr10_-_28986280 | 0.60 |
ENSMUST00000152363.1
ENSMUST00000015663.6 |
2310057J18Rik
|
RIKEN cDNA 2310057J18 gene |
chr4_+_141239499 | 0.58 |
ENSMUST00000141834.2
|
Arhgef19
|
Rho guanine nucleotide exchange factor (GEF) 19 |
chr1_+_72284367 | 0.58 |
ENSMUST00000027380.5
ENSMUST00000141783.1 |
Tmem169
|
transmembrane protein 169 |
chr9_+_75311395 | 0.57 |
ENSMUST00000076889.6
|
Gnb5
|
guanine nucleotide binding protein (G protein), beta 5 |
chr1_+_88087802 | 0.57 |
ENSMUST00000113139.1
|
Ugt1a8
|
UDP glucuronosyltransferase 1 family, polypeptide A8 |
chr6_+_134830216 | 0.57 |
ENSMUST00000111937.1
|
Crebl2
|
cAMP responsive element binding protein-like 2 |
chr17_+_91088493 | 0.57 |
ENSMUST00000095183.1
|
Gm10308
|
predicted gene 10308 |
chr7_+_141078188 | 0.56 |
ENSMUST00000106039.2
|
Pkp3
|
plakophilin 3 |
chr5_+_30913398 | 0.56 |
ENSMUST00000031055.5
|
Emilin1
|
elastin microfibril interfacer 1 |
chr10_+_69212676 | 0.56 |
ENSMUST00000167384.1
|
Rhobtb1
|
Rho-related BTB domain containing 1 |
chr17_+_70561739 | 0.56 |
ENSMUST00000097288.2
|
Dlgap1
|
discs, large (Drosophila) homolog-associated protein 1 |
chr14_-_110755100 | 0.56 |
ENSMUST00000078386.2
|
Slitrk6
|
SLIT and NTRK-like family, member 6 |
chr12_-_11436607 | 0.53 |
ENSMUST00000072299.5
|
Vsnl1
|
visinin-like 1 |
chr18_-_80713062 | 0.53 |
ENSMUST00000170905.1
ENSMUST00000078049.4 |
Nfatc1
|
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 1 |
chr5_+_117363513 | 0.53 |
ENSMUST00000111959.1
|
Wsb2
|
WD repeat and SOCS box-containing 2 |
chrX_-_57338598 | 0.52 |
ENSMUST00000033468.4
ENSMUST00000114736.1 |
Arhgef6
|
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 |
chr12_+_24651346 | 0.52 |
ENSMUST00000020982.5
|
Klf11
|
Kruppel-like factor 11 |
chr12_+_69790288 | 0.52 |
ENSMUST00000021378.3
|
4930512B01Rik
|
RIKEN cDNA 4930512B01 gene |
chr5_+_24423851 | 0.52 |
ENSMUST00000141966.1
|
Slc4a2
|
solute carrier family 4 (anion exchanger), member 2 |
chr16_-_22161450 | 0.52 |
ENSMUST00000115379.1
|
Igf2bp2
|
insulin-like growth factor 2 mRNA binding protein 2 |
chr13_-_92131494 | 0.51 |
ENSMUST00000099326.3
ENSMUST00000146492.1 |
Rasgrf2
|
RAS protein-specific guanine nucleotide-releasing factor 2 |
chrX_+_7607099 | 0.51 |
ENSMUST00000115726.2
ENSMUST00000133637.1 ENSMUST00000115725.2 |
Cacna1f
|
calcium channel, voltage-dependent, alpha 1F subunit |
chr6_-_5496296 | 0.51 |
ENSMUST00000019721.4
|
Pdk4
|
pyruvate dehydrogenase kinase, isoenzyme 4 |
chr18_-_60648290 | 0.51 |
ENSMUST00000143275.2
|
Synpo
|
synaptopodin |
chr11_-_102107822 | 0.51 |
ENSMUST00000177304.1
ENSMUST00000017455.8 |
Pyy
|
peptide YY |
chr18_-_44662251 | 0.51 |
ENSMUST00000164666.1
|
Mcc
|
mutated in colorectal cancers |
chr15_-_101370125 | 0.50 |
ENSMUST00000077196.4
|
Krt80
|
keratin 80 |
chr3_+_159839729 | 0.50 |
ENSMUST00000068952.5
|
Wls
|
wntless homolog (Drosophila) |
chr13_+_40859768 | 0.50 |
ENSMUST00000110191.2
|
Gcnt2
|
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme |
chr2_+_21367532 | 0.50 |
ENSMUST00000055946.7
|
Gpr158
|
G protein-coupled receptor 158 |
chr11_+_85353156 | 0.49 |
ENSMUST00000108061.1
ENSMUST00000108062.1 ENSMUST00000108056.1 ENSMUST00000138423.1 ENSMUST00000074875.4 ENSMUST00000092821.3 |
Bcas3
|
breast carcinoma amplified sequence 3 |
chr11_-_47379405 | 0.49 |
ENSMUST00000077221.5
|
Sgcd
|
sarcoglycan, delta (dystrophin-associated glycoprotein) |
chr12_+_33314277 | 0.49 |
ENSMUST00000133549.1
|
Atxn7l1
|
ataxin 7-like 1 |
chr10_+_79997463 | 0.49 |
ENSMUST00000171637.1
ENSMUST00000043866.7 |
Abca7
|
ATP-binding cassette, sub-family A (ABC1), member 7 |
chr7_+_99535652 | 0.48 |
ENSMUST00000032995.8
ENSMUST00000162404.1 |
Arrb1
|
arrestin, beta 1 |
chr8_+_62951361 | 0.48 |
ENSMUST00000119068.1
|
Spock3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 3 |
chr2_+_158375638 | 0.48 |
ENSMUST00000109488.1
|
Snhg11
|
small nucleolar RNA host gene 11 |
chrX_+_164140447 | 0.47 |
ENSMUST00000073973.4
|
Ace2
|
angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 |
chr8_-_67818284 | 0.47 |
ENSMUST00000120071.1
|
Psd3
|
pleckstrin and Sec7 domain containing 3 |
chrX_+_103422010 | 0.47 |
ENSMUST00000182089.1
|
Gm26992
|
predicted gene, 26992 |
chr11_+_100545607 | 0.47 |
ENSMUST00000092684.5
ENSMUST00000006976.7 |
Ttc25
|
tetratricopeptide repeat domain 25 |
chr2_-_18048784 | 0.47 |
ENSMUST00000142856.1
|
Skida1
|
SKI/DACH domain containing 1 |
chr7_+_75701965 | 0.46 |
ENSMUST00000094307.3
|
Akap13
|
A kinase (PRKA) anchor protein 13 |
chr9_+_67840386 | 0.46 |
ENSMUST00000077879.5
|
Vps13c
|
vacuolar protein sorting 13C (yeast) |
chr18_+_50051702 | 0.46 |
ENSMUST00000134348.1
ENSMUST00000153873.2 |
Tnfaip8
|
tumor necrosis factor, alpha-induced protein 8 |
chr18_+_37020097 | 0.45 |
ENSMUST00000047614.1
|
Pcdha2
|
protocadherin alpha 2 |
chrX_-_143933089 | 0.45 |
ENSMUST00000087313.3
|
Dcx
|
doublecortin |
chr10_+_116301374 | 0.45 |
ENSMUST00000092167.5
|
Ptprb
|
protein tyrosine phosphatase, receptor type, B |
chr2_+_112265809 | 0.45 |
ENSMUST00000110991.2
|
Slc12a6
|
solute carrier family 12, member 6 |
chr1_+_74601548 | 0.45 |
ENSMUST00000087186.4
|
Stk36
|
serine/threonine kinase 36 |
chr4_-_3938354 | 0.45 |
ENSMUST00000003369.3
|
Plag1
|
pleiomorphic adenoma gene 1 |
chr4_+_82065855 | 0.44 |
ENSMUST00000151038.1
|
Gm5860
|
predicted gene 5860 |
chr18_-_46728342 | 0.44 |
ENSMUST00000035804.7
|
Cdo1
|
cysteine dioxygenase 1, cytosolic |
chr7_+_134670667 | 0.43 |
ENSMUST00000084488.4
|
Dock1
|
dedicator of cytokinesis 1 |
chr16_+_17331371 | 0.43 |
ENSMUST00000023450.6
ENSMUST00000161034.1 |
Serpind1
|
serine (or cysteine) peptidase inhibitor, clade D, member 1 |
chr18_+_37442517 | 0.43 |
ENSMUST00000056915.1
|
Pcdhb13
|
protocadherin beta 13 |
chr19_+_6341121 | 0.43 |
ENSMUST00000025897.6
ENSMUST00000130382.1 |
Map4k2
|
mitogen-activated protein kinase kinase kinase kinase 2 |
chr13_-_23761223 | 0.43 |
ENSMUST00000102964.2
|
Hist1h4a
|
histone cluster 1, H4a |
chr3_+_96670131 | 0.43 |
ENSMUST00000048427.5
|
Ankrd35
|
ankyrin repeat domain 35 |
chr10_-_20724696 | 0.43 |
ENSMUST00000170265.1
|
Pde7b
|
phosphodiesterase 7B |
chr11_+_29692937 | 0.43 |
ENSMUST00000102843.3
ENSMUST00000102842.3 ENSMUST00000078830.4 ENSMUST00000170731.1 |
Rtn4
|
reticulon 4 |
chr13_-_8871751 | 0.42 |
ENSMUST00000175958.1
|
Wdr37
|
WD repeat domain 37 |
chr14_-_70627008 | 0.42 |
ENSMUST00000110984.2
|
Dmtn
|
dematin actin binding protein |
chr19_+_22139028 | 0.42 |
ENSMUST00000099569.2
ENSMUST00000087576.4 ENSMUST00000074770.5 |
Trpm3
|
transient receptor potential cation channel, subfamily M, member 3 |
chr5_-_148995147 | 0.42 |
ENSMUST00000147473.1
|
Katnal1
|
katanin p60 subunit A-like 1 |
chr3_-_8667033 | 0.42 |
ENSMUST00000042412.3
|
Hey1
|
hairy/enhancer-of-split related with YRPW motif 1 |
chr17_+_35841668 | 0.42 |
ENSMUST00000174124.1
|
Mdc1
|
mediator of DNA damage checkpoint 1 |
chr7_-_19421326 | 0.42 |
ENSMUST00000047020.1
|
A930016O22Rik
|
RIKEN cDNA A930016O22 gene |
chr7_-_79842287 | 0.41 |
ENSMUST00000049004.6
|
Anpep
|
alanyl (membrane) aminopeptidase |
chr7_-_100656953 | 0.41 |
ENSMUST00000107046.1
ENSMUST00000107045.1 ENSMUST00000139708.1 |
Plekhb1
|
pleckstrin homology domain containing, family B (evectins) member 1 |
chr17_+_6106464 | 0.41 |
ENSMUST00000142030.1
|
Tulp4
|
tubby like protein 4 |
chr18_-_35215008 | 0.41 |
ENSMUST00000091636.3
|
Lrrtm2
|
leucine rich repeat transmembrane neuronal 2 |
chr16_-_32797413 | 0.41 |
ENSMUST00000115116.1
ENSMUST00000041123.8 |
Muc20
|
mucin 20 |
chr5_+_102724971 | 0.41 |
ENSMUST00000112853.1
|
Arhgap24
|
Rho GTPase activating protein 24 |
chr3_+_122895072 | 0.41 |
ENSMUST00000023820.5
|
Fabp2
|
fatty acid binding protein 2, intestinal |
chr6_+_86849488 | 0.41 |
ENSMUST00000089519.6
ENSMUST00000113668.1 |
Aak1
|
AP2 associated kinase 1 |
chr16_-_31314804 | 0.41 |
ENSMUST00000115230.1
ENSMUST00000130560.1 |
Apod
|
apolipoprotein D |
chr6_+_29859686 | 0.41 |
ENSMUST00000134438.1
|
Ahcyl2
|
S-adenosylhomocysteine hydrolase-like 2 |
chr7_-_104353328 | 0.41 |
ENSMUST00000130139.1
ENSMUST00000059037.8 |
Trim12c
|
tripartite motif-containing 12C |
chr10_-_115185015 | 0.40 |
ENSMUST00000006949.8
|
Tph2
|
tryptophan hydroxylase 2 |
chr6_+_87730869 | 0.40 |
ENSMUST00000159570.2
ENSMUST00000032132.8 |
Efcc1
|
EF hand and coiled-coil domain containing 1 |
chr9_+_111271832 | 0.40 |
ENSMUST00000060711.5
|
Epm2aip1
|
EPM2A (laforin) interacting protein 1 |
chr10_-_20725023 | 0.40 |
ENSMUST00000020165.7
|
Pde7b
|
phosphodiesterase 7B |
chr5_-_142817387 | 0.40 |
ENSMUST00000036253.6
|
Tnrc18
|
trinucleotide repeat containing 18 |
chr9_-_75597643 | 0.40 |
ENSMUST00000164100.1
|
Tmod2
|
tropomodulin 2 |
chr3_+_40540751 | 0.40 |
ENSMUST00000091186.3
|
Intu
|
inturned planar cell polarity effector homolog (Drosophila) |
chr15_-_59082026 | 0.40 |
ENSMUST00000080371.6
|
Mtss1
|
metastasis suppressor 1 |
chr16_-_44139630 | 0.40 |
ENSMUST00000137557.1
ENSMUST00000147025.1 |
Atp6v1a
|
ATPase, H+ transporting, lysosomal V1 subunit A |
chr7_+_83584910 | 0.40 |
ENSMUST00000039317.7
ENSMUST00000164944.1 |
Tmc3
|
transmembrane channel-like gene family 3 |
chr14_-_124677089 | 0.40 |
ENSMUST00000095529.3
|
Fgf14
|
fibroblast growth factor 14 |
chr10_+_69212634 | 0.40 |
ENSMUST00000020101.5
|
Rhobtb1
|
Rho-related BTB domain containing 1 |
chr5_+_66968416 | 0.40 |
ENSMUST00000038188.7
|
Limch1
|
LIM and calponin homology domains 1 |
chr4_-_43429117 | 0.40 |
ENSMUST00000171134.2
ENSMUST00000052829.3 |
Fam166b
|
family with sequence similarity 166, member B |
chr10_+_81575499 | 0.39 |
ENSMUST00000143285.1
ENSMUST00000146358.1 |
Tle2
|
transducin-like enhancer of split 2, homolog of Drosophila E(spl) |
chr4_-_49549523 | 0.39 |
ENSMUST00000029987.9
|
Aldob
|
aldolase B, fructose-bisphosphate |
chr17_+_34204080 | 0.39 |
ENSMUST00000138491.1
|
Tap2
|
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) |
chr14_+_60732906 | 0.39 |
ENSMUST00000162945.1
|
Spata13
|
spermatogenesis associated 13 |
chr3_+_100489508 | 0.39 |
ENSMUST00000122898.1
|
Gm12474
|
predicted gene 12474 |
chr1_-_156204998 | 0.39 |
ENSMUST00000015628.3
|
Fam163a
|
family with sequence similarity 163, member A |
chr2_-_52558539 | 0.39 |
ENSMUST00000102760.3
ENSMUST00000102761.2 |
Cacnb4
|
calcium channel, voltage-dependent, beta 4 subunit |
chr5_-_151233818 | 0.39 |
ENSMUST00000126770.1
|
Stard13
|
StAR-related lipid transfer (START) domain containing 13 |
chr6_+_134830145 | 0.39 |
ENSMUST00000046303.5
|
Crebl2
|
cAMP responsive element binding protein-like 2 |
chr7_-_68749170 | 0.39 |
ENSMUST00000118110.1
ENSMUST00000048068.7 |
Arrdc4
|
arrestin domain containing 4 |
chr1_+_170214826 | 0.39 |
ENSMUST00000159201.1
ENSMUST00000055830.1 |
4930500M09Rik
|
RIKEN cDNA 4930500M09 gene |
chr7_+_99535439 | 0.39 |
ENSMUST00000098266.2
ENSMUST00000179755.1 |
Arrb1
|
arrestin, beta 1 |
chr6_+_29859662 | 0.39 |
ENSMUST00000128927.2
|
Ahcyl2
|
S-adenosylhomocysteine hydrolase-like 2 |
chr10_-_93310963 | 0.38 |
ENSMUST00000151153.1
|
Elk3
|
ELK3, member of ETS oncogene family |
chr6_+_77242715 | 0.38 |
ENSMUST00000161677.1
|
Lrrtm1
|
leucine rich repeat transmembrane neuronal 1 |
chr10_-_93311073 | 0.38 |
ENSMUST00000008542.5
|
Elk3
|
ELK3, member of ETS oncogene family |
chr18_-_80247102 | 0.38 |
ENSMUST00000166219.1
|
Hsbp1l1
|
heat shock factor binding protein 1-like 1 |
chr10_-_41579207 | 0.38 |
ENSMUST00000095227.3
|
Ccdc162
|
coiled-coil domain containing 162 |
chr1_-_57970032 | 0.38 |
ENSMUST00000159826.1
|
Kctd18
|
potassium channel tetramerisation domain containing 18 |
chr9_+_107580746 | 0.38 |
ENSMUST00000148440.1
|
Hyal3
|
hyaluronoglucosaminidase 3 |
chr7_+_43562256 | 0.37 |
ENSMUST00000107972.1
|
Zfp658
|
zinc finger protein 658 |
chr18_+_37333853 | 0.37 |
ENSMUST00000061717.2
|
Pcdhb6
|
protocadherin beta 6 |
chr11_+_110399115 | 0.37 |
ENSMUST00000020949.5
ENSMUST00000100260.1 |
Map2k6
|
mitogen-activated protein kinase kinase 6 |
chr16_-_97170707 | 0.37 |
ENSMUST00000056102.7
|
Dscam
|
Down syndrome cell adhesion molecule |
chr8_+_45627946 | 0.37 |
ENSMUST00000145458.1
|
Sorbs2
|
sorbin and SH3 domain containing 2 |
chr19_-_37176055 | 0.37 |
ENSMUST00000142973.1
ENSMUST00000154376.1 |
Cpeb3
|
cytoplasmic polyadenylation element binding protein 3 |
chr5_+_3571664 | 0.37 |
ENSMUST00000008451.5
|
1700109H08Rik
|
RIKEN cDNA 1700109H08 gene |
chr7_-_133702515 | 0.37 |
ENSMUST00000153698.1
|
Uros
|
uroporphyrinogen III synthase |
chr7_+_27195781 | 0.36 |
ENSMUST00000108379.1
ENSMUST00000179391.1 |
BC024978
|
cDNA sequence BC024978 |
chr3_+_28263563 | 0.36 |
ENSMUST00000160307.2
ENSMUST00000159680.2 ENSMUST00000160518.1 ENSMUST00000162485.1 ENSMUST00000159308.1 ENSMUST00000162777.1 ENSMUST00000161964.1 |
Tnik
|
TRAF2 and NCK interacting kinase |
chr12_-_75177325 | 0.36 |
ENSMUST00000042299.2
|
Kcnh5
|
potassium voltage-gated channel, subfamily H (eag-related), member 5 |
chr11_-_50841546 | 0.36 |
ENSMUST00000109133.1
ENSMUST00000109134.1 ENSMUST00000049625.1 |
Zfp879
|
zinc finger protein 879 |
chr2_+_121867083 | 0.36 |
ENSMUST00000089912.5
ENSMUST00000089915.3 |
Casc4
|
cancer susceptibility candidate 4 |
chr14_+_51984857 | 0.36 |
ENSMUST00000100639.4
ENSMUST00000182909.1 ENSMUST00000182760.1 ENSMUST00000182061.1 ENSMUST00000182193.1 |
Arhgef40
|
Rho guanine nucleotide exchange factor (GEF) 40 |
chr7_+_12881165 | 0.36 |
ENSMUST00000144578.1
|
Zfp128
|
zinc finger protein 128 |
chr5_+_81021583 | 0.36 |
ENSMUST00000121707.1
|
Lphn3
|
latrophilin 3 |
chr5_-_88527841 | 0.36 |
ENSMUST00000087033.3
|
Igj
|
immunoglobulin joining chain |
chr19_-_56822161 | 0.35 |
ENSMUST00000118592.1
|
A630007B06Rik
|
RIKEN cDNA A630007B06 gene |
chr5_+_35893319 | 0.35 |
ENSMUST00000064571.4
|
Afap1
|
actin filament associated protein 1 |
chr5_+_24423805 | 0.35 |
ENSMUST00000153274.1
|
Slc4a2
|
solute carrier family 4 (anion exchanger), member 2 |
chr17_+_6270475 | 0.35 |
ENSMUST00000088940.4
|
Tmem181a
|
transmembrane protein 181A |
chr10_-_53647080 | 0.35 |
ENSMUST00000169866.1
|
Fam184a
|
family with sequence similarity 184, member A |
chr19_-_5797410 | 0.35 |
ENSMUST00000173314.1
|
Malat1
|
metastasis associated lung adenocarcinoma transcript 1 (non-coding RNA) |
chr16_-_19983005 | 0.35 |
ENSMUST00000058839.8
|
Klhl6
|
kelch-like 6 |
chr5_-_104021799 | 0.35 |
ENSMUST00000119025.1
|
Hsd17b11
|
hydroxysteroid (17-beta) dehydrogenase 11 |
chrX_-_7681034 | 0.35 |
ENSMUST00000115695.3
|
Magix
|
MAGI family member, X-linked |
chr14_-_72602945 | 0.35 |
ENSMUST00000162825.1
|
Fndc3a
|
fibronectin type III domain containing 3A |
chr8_+_3515378 | 0.35 |
ENSMUST00000004681.7
ENSMUST00000111070.2 |
Pnpla6
|
patatin-like phospholipase domain containing 6 |
chr11_+_48837465 | 0.34 |
ENSMUST00000046903.5
|
Trim7
|
tripartite motif-containing 7 |
chr4_+_63215402 | 0.34 |
ENSMUST00000036300.6
|
Col27a1
|
collagen, type XXVII, alpha 1 |
chr11_+_103133333 | 0.34 |
ENSMUST00000124928.1
ENSMUST00000062530.4 |
Hexim2
|
hexamethylene bis-acetamide inducible 2 |
chr3_-_84259812 | 0.34 |
ENSMUST00000107691.1
|
Trim2
|
tripartite motif-containing 2 |
chr7_+_27692502 | 0.34 |
ENSMUST00000076421.6
|
C030039L03Rik
|
RIKEN cDNA C030039L03 gene |
chr11_-_62458508 | 0.34 |
ENSMUST00000141447.1
|
Ncor1
|
nuclear receptor co-repressor 1 |
chr14_+_118137101 | 0.34 |
ENSMUST00000022728.2
|
Gpr180
|
G protein-coupled receptor 180 |
chr19_+_5298302 | 0.34 |
ENSMUST00000061169.6
|
Gal3st3
|
galactose-3-O-sulfotransferase 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.3 | GO:0090126 | protein complex assembly involved in synapse maturation(GO:0090126) |
0.3 | 0.8 | GO:0009804 | coumarin metabolic process(GO:0009804) phenylpropanoid catabolic process(GO:0046271) |
0.3 | 1.6 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.2 | 1.1 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.2 | 0.7 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.2 | 0.7 | GO:0031554 | regulation of DNA-templated transcription, termination(GO:0031554) |
0.2 | 0.7 | GO:0034442 | regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) |
0.2 | 0.6 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
0.2 | 0.6 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) peptide antigen transport(GO:0046968) |
0.2 | 1.4 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.2 | 0.5 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
0.2 | 0.7 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) positive regulation of oocyte development(GO:0060282) |
0.2 | 0.5 | GO:0021934 | hindbrain tangential cell migration(GO:0021934) |
0.2 | 0.9 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.2 | 0.5 | GO:0006710 | androgen catabolic process(GO:0006710) |
0.2 | 0.5 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
0.2 | 0.6 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.1 | 0.4 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.1 | 0.9 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 0.4 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
0.1 | 0.5 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
0.1 | 1.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.4 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.1 | 0.5 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
0.1 | 0.5 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.1 | 0.4 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.1 | 0.4 | GO:0002182 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
0.1 | 0.4 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 0.5 | GO:0015801 | aromatic amino acid transport(GO:0015801) tryptophan transport(GO:0015827) |
0.1 | 0.5 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
0.1 | 0.6 | GO:0002159 | desmosome assembly(GO:0002159) |
0.1 | 0.3 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) formin-nucleated actin cable assembly(GO:0070649) |
0.1 | 0.4 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.1 | 0.5 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.1 | 0.6 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.3 | GO:0060166 | olfactory pit development(GO:0060166) |
0.1 | 0.3 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.1 | 0.3 | GO:1903903 | positive regulation of keratinocyte apoptotic process(GO:1902174) regulation of establishment of T cell polarity(GO:1903903) |
0.1 | 1.1 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.3 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 0.5 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.1 | 0.3 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.1 | 0.6 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.4 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.1 | 0.3 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
0.1 | 0.3 | GO:0002194 | hepatocyte cell migration(GO:0002194) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
0.1 | 0.3 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.1 | 0.4 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) |
0.1 | 0.3 | GO:0061193 | taste bud development(GO:0061193) |
0.1 | 0.3 | GO:0050973 | detection of mechanical stimulus involved in equilibrioception(GO:0050973) |
0.1 | 0.4 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 0.5 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.3 | GO:0072362 | regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072362) |
0.1 | 0.9 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.4 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.2 | GO:0048003 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.3 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.1 | 0.5 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.3 | GO:0033380 | protein localization to secretory granule(GO:0033366) protein localization to mast cell secretory granule(GO:0033367) protease localization to mast cell secretory granule(GO:0033368) maintenance of protein location in mast cell secretory granule(GO:0033370) T cell secretory granule organization(GO:0033371) maintenance of protease location in mast cell secretory granule(GO:0033373) protein localization to T cell secretory granule(GO:0033374) protease localization to T cell secretory granule(GO:0033375) maintenance of protein location in T cell secretory granule(GO:0033377) maintenance of protease location in T cell secretory granule(GO:0033379) granzyme B localization to T cell secretory granule(GO:0033380) maintenance of granzyme B location in T cell secretory granule(GO:0033382) |
0.1 | 0.5 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.3 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.1 | 0.6 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.4 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) response to glucagon(GO:0033762) |
0.1 | 0.3 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.1 | 0.8 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.4 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.1 | 0.3 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.1 | 0.3 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.1 | 1.0 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.1 | 0.3 | GO:0014854 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.1 | 0.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.1 | 0.4 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.1 | 0.2 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
0.1 | 0.3 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.1 | 0.5 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) regulation of mitophagy in response to mitochondrial depolarization(GO:1904923) |
0.1 | 0.5 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.3 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.1 | 0.3 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.2 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.1 | 0.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.1 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.1 | 0.2 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.1 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.1 | 0.2 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.1 | 0.9 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.2 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
0.1 | 0.3 | GO:0035564 | regulation of kidney size(GO:0035564) |
0.1 | 0.5 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.1 | 0.2 | GO:1904636 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
0.1 | 0.2 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.1 | 0.3 | GO:0003431 | growth plate cartilage chondrocyte differentiation(GO:0003418) growth plate cartilage chondrocyte development(GO:0003431) |
0.1 | 0.4 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.3 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.1 | 0.7 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.4 | GO:0070472 | uterine smooth muscle contraction(GO:0070471) regulation of uterine smooth muscle contraction(GO:0070472) positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.1 | 0.2 | GO:1900275 | negative regulation of phospholipase C activity(GO:1900275) |
0.1 | 0.2 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.1 | 0.3 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.1 | 0.2 | GO:0045608 | negative regulation of auditory receptor cell differentiation(GO:0045608) |
0.1 | 0.2 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.1 | 1.0 | GO:0030575 | nuclear body organization(GO:0030575) |
0.1 | 0.3 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.1 | 0.3 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
0.1 | 0.4 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.2 | GO:1903896 | positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
0.1 | 0.4 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.4 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.1 | 0.2 | GO:0007308 | oocyte construction(GO:0007308) oocyte axis specification(GO:0007309) oocyte anterior/posterior axis specification(GO:0007314) pole plasm assembly(GO:0007315) maternal determination of anterior/posterior axis, embryo(GO:0008358) P granule organization(GO:0030719) |
0.1 | 0.2 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.0 | 0.3 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.0 | 0.2 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
0.0 | 0.7 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.0 | 0.2 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.0 | 0.7 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.0 | 0.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.1 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.0 | 0.3 | GO:0090005 | protein depalmitoylation(GO:0002084) negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.2 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.0 | 0.2 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.0 | 0.2 | GO:0015692 | vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) |
0.0 | 0.3 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.0 | 0.8 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
0.0 | 0.3 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.0 | 0.4 | GO:0006568 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.0 | 0.6 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.3 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.0 | 0.2 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.0 | 0.1 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
0.0 | 0.1 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.0 | 0.1 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.0 | 0.2 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.0 | 0.3 | GO:0015808 | L-alanine transport(GO:0015808) |
0.0 | 0.1 | GO:0021759 | globus pallidus development(GO:0021759) |
0.0 | 0.3 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.6 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.0 | 0.1 | GO:0019660 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.0 | 0.5 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.0 | 0.1 | GO:2000256 | positive regulation of male germ cell proliferation(GO:2000256) |
0.0 | 0.2 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.0 | 0.1 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.0 | 0.1 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.0 | 0.1 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) |
0.0 | 0.1 | GO:1903760 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) |
0.0 | 0.5 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.2 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.0 | 0.1 | GO:0021586 | pons maturation(GO:0021586) |
0.0 | 0.3 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.0 | 0.5 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.0 | 0.1 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.0 | 0.1 | GO:0030070 | insulin processing(GO:0030070) |
0.0 | 0.4 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.0 | 0.2 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) |
0.0 | 0.2 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.0 | 0.1 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.0 | 0.5 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.0 | 0.1 | GO:0072244 | metanephric glomerular epithelium development(GO:0072244) |
0.0 | 0.4 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.1 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.0 | 0.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.1 | GO:0032917 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.0 | 0.1 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.0 | 0.3 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.0 | 0.2 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.0 | 0.3 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.0 | 0.2 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.0 | 0.2 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.0 | 0.3 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.0 | 0.2 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.0 | 0.7 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.0 | 0.3 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.0 | 0.1 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.0 | 0.2 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.1 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.0 | 0.1 | GO:1905077 | negative regulation of interleukin-17 secretion(GO:1905077) |
0.0 | 0.2 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.0 | 0.4 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 0.2 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.0 | 0.1 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.0 | 0.3 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.3 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.4 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.2 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.0 | 0.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.0 | 0.1 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.0 | 0.2 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 0.2 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.0 | 0.1 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.0 | 0.4 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.0 | 0.9 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.0 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.0 | 0.1 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.0 | 0.1 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.0 | 0.3 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.0 | 0.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.1 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.0 | 0.4 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.0 | 0.3 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.0 | 0.2 | GO:0010991 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.0 | 0.4 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.0 | 0.7 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.2 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.0 | 0.5 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.0 | 0.2 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.0 | 0.2 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.0 | 0.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.0 | 0.2 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.0 | 1.0 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.0 | 0.2 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.0 | 0.9 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.3 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.2 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.0 | 0.2 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.1 | GO:0060596 | mammary placode formation(GO:0060596) |
0.0 | 0.4 | GO:0099612 | protein localization to axon(GO:0099612) |
0.0 | 0.5 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.0 | 0.1 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.0 | 0.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.0 | 0.5 | GO:0006903 | vesicle targeting(GO:0006903) |
0.0 | 0.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.0 | 0.1 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.0 | 0.5 | GO:0007097 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
0.0 | 0.0 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.0 | 0.5 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.0 | 0.1 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
0.0 | 0.1 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.0 | 0.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.1 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) cerebral cortex GABAergic interneuron development(GO:0021894) |
0.0 | 0.1 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.0 | 0.0 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.0 | 0.1 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.1 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) negative regulation of execution phase of apoptosis(GO:1900118) |
0.0 | 0.2 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.1 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.0 | 0.2 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.1 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.0 | 0.2 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.0 | 0.5 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.0 | 0.2 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.8 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.0 | 0.1 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.0 | 0.0 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.2 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.1 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.0 | 0.6 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 0.2 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.0 | 0.2 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.0 | 0.1 | GO:0021993 | fourth ventricle development(GO:0021592) initiation of neural tube closure(GO:0021993) |
0.0 | 0.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.0 | 0.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.5 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.0 | 0.2 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
0.0 | 2.1 | GO:0007416 | synapse assembly(GO:0007416) |
0.0 | 0.2 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.1 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.0 | 0.4 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.1 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.0 | 0.2 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.0 | 0.9 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.0 | 0.4 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.0 | 0.3 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.3 | GO:0051642 | centrosome localization(GO:0051642) |
0.0 | 1.8 | GO:0055001 | muscle cell development(GO:0055001) |
0.0 | 0.0 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
0.0 | 0.0 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 0.2 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.0 | 0.0 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.0 | 1.3 | GO:0006821 | chloride transport(GO:0006821) |
0.0 | 0.1 | GO:0046541 | saliva secretion(GO:0046541) |
0.0 | 0.1 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.0 | 0.1 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.0 | 0.1 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.0 | 0.1 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.0 | 0.2 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.0 | 0.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.1 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.0 | 0.0 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.0 | 0.1 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.0 | 0.3 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.0 | GO:0021564 | vagus nerve development(GO:0021564) |
0.0 | 0.9 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.0 | 0.2 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.1 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.1 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.0 | 0.3 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.3 | GO:0015807 | L-amino acid transport(GO:0015807) |
0.0 | 0.2 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.0 | 0.2 | GO:0030220 | platelet formation(GO:0030220) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 3.2 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.2 | 1.1 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.2 | 0.8 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 0.6 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 0.4 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.1 | 0.4 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.1 | 0.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.7 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.4 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 0.8 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.8 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 0.5 | GO:0097444 | spine apparatus(GO:0097444) |
0.1 | 1.2 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.6 | GO:0042825 | TAP complex(GO:0042825) |
0.1 | 0.4 | GO:1990462 | omegasome(GO:1990462) |
0.1 | 0.8 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.3 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 0.2 | GO:0044393 | microspike(GO:0044393) |
0.1 | 0.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 0.3 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.1 | 0.9 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 0.2 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.0 | 0.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.2 | GO:0097447 | dendritic tree(GO:0097447) |
0.0 | 0.1 | GO:0044753 | amphisome(GO:0044753) multivesicular body, internal vesicle(GO:0097487) |
0.0 | 0.8 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.5 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 0.5 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.5 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.4 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.3 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.2 | GO:0070826 | paraferritin complex(GO:0070826) |
0.0 | 0.2 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.0 | 0.1 | GO:0044307 | dendritic branch(GO:0044307) |
0.0 | 0.4 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.4 | GO:0071439 | clathrin complex(GO:0071439) |
0.0 | 0.1 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.0 | 0.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 0.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.3 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 0.2 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.0 | 0.2 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.0 | 0.5 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.3 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.3 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.0 | 1.0 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.3 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.0 | 0.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.0 | 0.1 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.0 | 0.2 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.0 | 0.6 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.3 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 2.3 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.1 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.2 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
0.0 | 0.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.6 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 0.4 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.1 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.0 | 0.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.2 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.1 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.0 | 0.2 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.1 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.0 | 0.1 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.1 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.0 | 0.2 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 0.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.4 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.0 | 0.4 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.0 | 0.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.0 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.0 | 0.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.1 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.0 | 0.1 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 0.3 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.5 | GO:0032590 | dendrite membrane(GO:0032590) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.2 | GO:0043656 | host cell cytoplasm(GO:0030430) host intracellular part(GO:0033646) host cell cytoplasm part(GO:0033655) intracellular region of host(GO:0043656) |
0.0 | 0.2 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.0 | 0.1 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.0 | 0.2 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.0 | 0.4 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.2 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 0.2 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.5 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.1 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.3 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 0.1 | GO:0097433 | dense body(GO:0097433) |
0.0 | 0.0 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.0 | 0.1 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.6 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.3 | 0.9 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
0.2 | 0.7 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.2 | 1.4 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 0.6 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.2 | 0.8 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 0.5 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
0.2 | 0.9 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 0.5 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.2 | 0.5 | GO:0034188 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.1 | 0.4 | GO:0035827 | rubidium ion transmembrane transporter activity(GO:0035827) |
0.1 | 0.4 | GO:0035939 | microsatellite binding(GO:0035939) |
0.1 | 0.5 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.5 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.1 | 0.4 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.1 | 1.0 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 0.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.6 | GO:0015433 | peptide antigen-transporting ATPase activity(GO:0015433) tapasin binding(GO:0046980) |
0.1 | 0.3 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 0.3 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 0.8 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 0.6 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 0.3 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
0.1 | 0.3 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.1 | 0.3 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.1 | 1.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.4 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.1 | 0.4 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
0.1 | 0.8 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.3 | GO:0005302 | hydrogen:amino acid symporter activity(GO:0005280) L-tyrosine transmembrane transporter activity(GO:0005302) |
0.1 | 0.3 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
0.1 | 1.0 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.1 | 0.5 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 0.7 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 0.7 | GO:0032564 | dATP binding(GO:0032564) |
0.1 | 0.5 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.1 | 0.2 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
0.1 | 0.3 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.5 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.1 | 0.2 | GO:1902271 | D3 vitamins binding(GO:1902271) |
0.1 | 0.3 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.1 | 0.3 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.1 | 0.2 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
0.1 | 0.1 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.1 | 0.4 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.1 | 0.2 | GO:0070737 | protein-glycine ligase activity, elongating(GO:0070737) |
0.1 | 0.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.2 | GO:0071820 | N-box binding(GO:0071820) |
0.1 | 0.4 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.5 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.1 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.3 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.3 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.3 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 0.5 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 0.2 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
0.1 | 1.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 0.2 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.0 | 0.1 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.0 | 1.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.5 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 0.2 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.2 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.0 | 0.2 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.0 | 0.6 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.2 | GO:0015094 | cadmium ion transmembrane transporter activity(GO:0015086) lead ion transmembrane transporter activity(GO:0015094) vanadium ion transmembrane transporter activity(GO:0015100) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.0 | 0.4 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.1 | GO:0050479 | glyceryl-ether monooxygenase activity(GO:0050479) |
0.0 | 0.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.1 | GO:0008520 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.0 | 0.2 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.0 | 0.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 1.2 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.3 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.7 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 0.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.6 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.1 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.0 | 0.1 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.0 | 0.1 | GO:0030977 | taurine binding(GO:0030977) |
0.0 | 0.3 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.5 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.4 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.2 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.0 | 0.2 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 0.2 | GO:0045340 | mercury ion binding(GO:0045340) |
0.0 | 0.1 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
0.0 | 0.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.3 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 0.6 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.0 | 0.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.7 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.6 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.3 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.0 | 0.4 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 0.2 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.0 | 0.2 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.0 | 0.3 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.0 | 0.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.3 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 0.1 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.0 | 1.1 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
0.0 | 0.1 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.0 | 0.2 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 0.3 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 2.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.5 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.2 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.0 | 0.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.1 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.0 | 0.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 0.5 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 0.6 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.2 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.0 | 0.1 | GO:0047710 | bis(5'-adenosyl)-triphosphatase activity(GO:0047710) |
0.0 | 0.3 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.6 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.2 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 0.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.0 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.0 | 0.6 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 1.6 | GO:0019905 | syntaxin binding(GO:0019905) |
0.0 | 0.1 | GO:0071253 | connexin binding(GO:0071253) |
0.0 | 0.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.3 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.1 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.0 | 0.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.0 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 0.3 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.1 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.0 | 0.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.1 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.0 | 0.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.9 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.2 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 0.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.6 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.1 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.0 | 0.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.1 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.1 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.0 | 0.0 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.0 | 0.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.0 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
0.0 | 0.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.0 | 0.8 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.2 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.2 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.2 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.0 | 0.3 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 0.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.2 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.4 | GO:0046875 | ephrin receptor binding(GO:0046875) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.4 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 1.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 1.3 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.8 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 2.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.4 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.9 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 1.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.5 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.6 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.8 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 0.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 0.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.7 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 0.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.4 | SIG CHEMOTAXIS | Genes related to chemotaxis |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 1.7 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 0.7 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.4 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.3 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 1.0 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.5 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 1.1 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 1.5 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.6 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.6 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.6 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.5 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.1 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.0 | 0.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 1.0 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.3 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 1.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 1.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 0.2 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 1.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.8 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.0 | 0.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.5 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.2 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.0 | 0.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.0 | 0.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.7 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.1 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.0 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.1 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |